KAIZHEN WANG: Open Payments
NPI 1972102374 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$208 in 6 payments from 4 companies in 2025. Trend: 2023 $224 · 2024 $73 · 2025 $208
Food & beverage: $208
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 2 | $115 |
| ABBVIE INC. | 2 | $52 |
| Janssen Biotech, Inc. | 1 | $24 |
| Aimmune Therapeutics, Inc. | 1 | $17 |
Products named: RINVOQ, TREMFYA, TEFLARO, ZENPEP.
Industry payments across TX — which companies pay providers there.
